The Innovative Health Initiative will see the scope of joint research between industry, academics and SMEs expand beyond pharmaceuticals, to include medical technology, biotech, digital health and vaccines
Researchers and public health leaders make a call ‘to build things that go beyond the politics’ as the best way of preserving collaboration in the future
During the 2014-16 Ebola outbreak in western Africa, public health expert Nicolas Meda of Burkina Faso played a key role in his country’s response to the epidemic. In an interview, he sets out the lessons learnt from the experience.
Advanced therapies feature in new Innovative Medicines Initiative Calls for proposals, along with topics on artificial intelligence; the need for reliable, relevant health information; and ways of incorporating patients’ perspectives into healthcare and cancer clinical trials.
IMI has involved patients in its projects and activities since the beginning. Now, IMI is creating a pool of patient experts to strengthen the role and voice of patients in IMI activities at strategic and operational levels.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.